Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.46 USD | -1.27% | -23.64% | +64.46% |
16/05 | UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating | MT |
07/05 | HC Wainwright Adjusts Price Target on Rani Therapeutics Holdings to $13 From $12, Maintains Buy Rating | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
15Cr | - | - | - | - | - | |
11TCr | ||||||
11TCr | ||||||
2.23TCr | - | |||||
2.22TCr | - | |||||
1.94TCr |